Bafna Pharmaceuticals Limited — Board Meeting, 11-11-2025: Outcome of Board Meeting
11-11-2025 | 05:46 pm
11-11-2025 | 05:46 pm
Bafna Pharmaceuticals' board held a meeting and approved the financial results for the quarter and half-year ended September 30, 2025. For the half-year, revenue from operations stood at ₹70.09 Cr, with a profit of ₹6.51 Cr and EPS of ₹2.75.
No comments yet. Be the first to comment!
